(Press-News.org) MINNEAPOLIS – A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson’s disease, according to a study published in the September 18, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
The study looked at sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are also known as gliflozins. They lower blood sugar by causing the kidneys to remove sugar from the body through urine.
“We know that these neurodegenerative diseases like dementia and Parkinson’s disease are common and the number of cases is growing as the population ages, and people with diabetes are at increased risk of cognitive impairment, so it’s encouraging to see that this class of drugs may provide some protection against dementia and Parkinson’s disease,” said study author Minyoung Lee, MD, PhD, of Yonsei University College of Medicine in Seoul, South Korea.
The retrospective study looked at people with type 2 diabetes who started diabetes medication from 2014 to 2019 in South Korea. People taking SGLT2 inhibitors were matched with people taking other oral diabetes drugs, so the two groups had people with similar ages, other health conditions and complications from diabetes. Then researchers followed the participants to see whether they developed dementia or Parkinson’s disease. Those taking the SGLT2 inhibitors were followed for an average of two years and those taking the other drugs were followed for an average of four years.
Among the 358,862 participants with an average age of 58, a total of 6,837 people developed dementia or Parkinson’s disease during the study.
For Alzheimer’s disease, the incidence rate for people taking SGLT2 inhibitors was 39.7 cases per 10,000 person-years, compared to 63.7 cases for those taking other diabetes drugs. Person-years represent both the number of people in the study and the amount of time each person spends in the study.
For vascular dementia, which is dementia caused by vascular disease, the incidence rate for people taking the SGLT2 drugs was 10.6 cases per 10,000, compared to 18.7 for those taking the other drugs.
For Parkinson’s disease, the incidence rate for those taking the SGLT2 drugs was 9.3 cases per 10,000, compared to 13.7 for those taking the other drugs.
After researchers adjusted for other factors that could affect the risk of dementia or Parkinson’s disease, such as complications from diabetes and medications, they found that SGLT2 inhibitor use was associated with a 20% reduced risk of Alzheimer’s disease and a 20% reduced risk of Parkinson’s disease. Those taking the drugs had a 30% reduced risk of developing vascular dementia.
“The results are generally consistent even after adjusting for factors like blood pressure, glucose, cholesterol and kidney function,” Lee said. “More research is needed to validate the long-term validity of these findings.”
Lee said that since participants were followed for less than five years at the most, it’s possible that some participants would later develop dementia or Parkinson’s disease.
The study was supported by the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare of Korea; Severance Hospital; and Yonsei University College of Medicine.
Learn more about brain health at BrainandLife.org, home of the American Academy of Neurology’s free patient and caregiver magazine focused on the intersection of neurologic disease and brain health. Follow Brain & Life® on Facebook, X and Instagram.
When posting to social media channels about this research, we encourage you to use the hashtags #Neurology and #AANscience.
The American Academy of Neurology is the world's largest association of neurologists and neuroscience professionals, with over 40,000 members. The AAN’s mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.
For more information about the American Academy of Neurology, visit AAN.com or find us on Facebook, X, Instagram, LinkedIn and YouTube.
END
Some diabetes drugs tied to lower risk of dementia, Parkinson’s disease
2024-09-18
ELSE PRESS RELEASES FROM THIS DATE:
Propagated corals reveal increased resistance to bleaching across the Caribbean during the fatal heatwave of 2023
2024-09-18
SECORE International’s Coral Seeding approach utilizes assisted reproduction, the breeding of corals, for reef restoration. This approach is realized within a training and partner network throughout the Caribbean. Now, a peer-reviewed study shows that all the effort was worthwhile: during the devastating heatwave in the Caribbean in 2023, the young, bred corals out on the reef stayed healthy while most of the remaining wild corals bleached and many died in the aftermath.
The summer of 2023 was deadly for many corals in the Caribbean Basin. An unprecedented heatwave, in intensity as well as in duration, hit the Caribbean with catastrophic ...
South African rock art possibly inspired by long-extinct species
2024-09-18
A mysterious tusked animal depicted in South African rock art might portray an ancient species preserved as fossils in the same region, according to a study published September 18, 2024 in the open-access journal PLOS ONE by Julien Benoit of the University of the Witwatersrand, Johannesburg, South Africa.
The Horned Serpent panel is a section of rock wall featuring artwork of animals and other cultural elements associated with the San people of South Africa, originally painted between 1821 and 1835. Among the painted figures is ...
Even marine animals in untouched habitats are at risk from human impacts
2024-09-18
Climate change and a range of other human impacts are putting marine animals at risk of extinction – even those living in almost pristine marine habitats and diverse coastal regions – reports a new study by Casey O'Hara of the National Center for Ecological Analysis and Synthesis at the University of California, Santa Barbara, USA, and colleagues, published September 18, 2024 in the open-access journal PLOS ONE.
Human activities on land and sea, in combination with climate change, are degrading coastal ...
Hexagonal electrohydraulic modules shape-shift into versatile robots
2024-09-18
Stuttgart – Scientists at the Max-Planck-Institute for Intelligent Systems (MPI-IS) have developed hexagon-shaped robotic components, called modules, that can be snapped together LEGO-style into high-speed robots that can be rearranged for different capabilities. The team of researchers from the Robotic Materials Department at MPI-IS, led by Christoph Keplinger, integrated artificial muscles into hexagonal exoskeletons that are embedded with magnets, allowing for quick mechanical and electrical connections. The team’s work, “Hexagonal electrohydraulic modules for rapidly reconfigurable high-speed robots” will be published in Science ...
Flexible circuits made with silk and graphene on the horizon
2024-09-18
RICHLAND, Wash.—After thousands of years as a highly valuable commodity, silk continues to surprise. Now it may help usher in a whole new direction for microelectronics and computing.
While silk protein has been deployed in designer electronics, its use is currently limited in part because silk fibers are a messy tangle of spaghetti-like strands.
Now, a research team led by scientists at the Department of Energy’s Pacific Northwest National Laboratory has tamed the tangle. They report in the journal ...
Scott Emr and Wesley Sundquist awarded 2024 Horwitz Prize for discovering the ESCRT pathway
2024-09-18
NEW YORK, NY (September 18, 2024)—Columbia University will award the 2024 Louisa Gross Horwitz Prize to Scott Emr and Wesley Sundquist for discovering the ESCRT (Endosomal Sorting Complexes Required for Transport) pathway and revealing how it works.
ESCRT (pronounced “escort”) complexes deform the cell membrane and bend parts of it away from the cytoplasm, the space that houses all material inside a cell. This unique process plays an essential role in keeping cells healthy by packaging and sorting molecules, removing waste, and regulating important functions such as cell division, neuron remodeling, ...
Versatile knee exo for safer lifting
2024-09-18
Images
A set of knee exoskeletons, built with commercially available knee braces and drone motors at the University of Michigan, has been shown to help counteract fatigue in lifting and carrying tasks. They helped users maintain better lifting posture even when tired, a key factor in defending against on-the-job injuries, the researchers say.
"Rather than directly bracing the back and giving up on proper lifting form, we strengthen the legs to maintain it," said Robert Gregg, U-M professor of robotics and corresponding author of the study in Science Robotics. "This differs from what's more commonly done in industry."
Already ...
NIH-led studies point to potential development of a cataract drug
2024-09-18
Researchers at the National Institutes of Health (NIH) and their collaborators have identified a protein, known as RNF114, that reverses cataracts, a clouding of the eye’s lens that occurs commonly in people as they age. The study, which was conducted in the 13-lined ground squirrel and rats, may represent a possible surgery-free strategy for managing cataracts, a common cause of vision loss. The study published in the Journal of Clinical Investigation.
“Scientists have long searched for an alternative to cataract surgery, which is effective, but not without risk. Lack of access to cataract surgery is a barrier to care in some ...
Artificial intelligence grunt work can be outsourced using a new blockchain-based framework developed by Concordians
2024-09-18
Tomorrow’s workplace will be run on mind-boggling amounts of data. To make sense of it all, businesses, developers and individuals will need better artificial intelligence (AI) systems, better trained AI workers and more efficient number-crunching servers.
While big tech companies have the resources and expertise to meet these demands, they remain beyond the reach of most small and medium-sized enterprises and individuals. To respond to this need, a Concordia-led international team of researchers has developed a new framework to make complex AI tasks more accessible ...
Mental health challenges faced by children with cystic fibrosis are the focus of a major, multisite study led by UB
2024-09-18
BUFFALO, N.Y. — A University at Buffalo psychiatrist who has played a critical role in getting mental health screening and treatment integrated into routine care for adults and adolescents with cystic fibrosis (CF) has been awarded $3 million from the Cystic Fibrosis Foundation to focus on the mental health of children with the disease.
Led by UB and launched this summer, the new study is an outgrowth of The International Depression Epidemiological Study (TIDES), which began in 2014 and was the largest study of mental health in adolescents and adults with CF. As a result of TIDES, ...